Clinical Trial Update: Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating Velcade (bortezomib) with thalidomide and dexamethasone, and panobinostat with panobinostat maintenance in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Panobinostat (Panobinostat)
• Thalidomide (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Prof Jamie Cavenagh | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN